Outcomes of correcting hyponatremia in patients with myocardial infarction

Waqas Qureshi1, Syed Hassan, Fatima Khalid

  • 1Department of Internal Medicine, Henry Ford Health Systems/Wayne State University School of Medicine, 2799 W Grand Blvd, CFP-1, Detroit, MI 48202, USA.

Insights

Hyponatremia in myocardial infarction patients predicts mortality, whether corrected or persistent. However, correcting hyponatremia may improve survival, especially with vaptan use.

Area of Science:

  • Cardiology
  • Internal Medicine
  • Clinical Research

Background:

  • Hyponatremia is a known predictor of poor outcomes in heart failure.
  • Its prognostic significance in myocardial infarction (MI) and the impact of correction remain unclear.

Purpose of the Study:

  • To assess the prognostic value of hyponatremia in MI patients.
  • To determine if correcting hyponatremia affects all-cause mortality.

Main Methods:

  • Retrospective analysis of 11,562 MI patients (2000-2010) with serum sodium measured within 24 hours of admission.
  • Multivariate and Cox proportional hazard models used to identify predictors of all-cause mortality and adjusted survival.

Main Results:

  • 1,535 deaths (13.3%) occurred over a mean follow-up of 5.5 years.
  • Both corrected (27.9% deaths) and persistent (55.3% deaths) hyponatremia independently predicted mortality (p < 0.0001).
  • Vaptan use was associated with reduced mortality in hyponatremic patients (HR 0.45; p=0.005).

Conclusions:

  • Hyponatremia, corrected or persistent, predicts mortality, major adverse cardiac events, and rehospitalization in MI patients.
  • Correction of hyponatremia can potentially improve patient survival.
  • Vaptans show promise in reducing mortality for hyponatremic MI patients.
Abstract

Related Concept Videos

Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Mitral Regurgitation IV: Nursing Management01:28

Mitral Regurgitation IV: Nursing Management

Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...